Europe: Sativex Coming to England, Spain 11/18/05

Drug War Chronicle, recent top items

more...

recent blog posts "In the Trenches" activist feed

SUBSCRIBE TODAY!!!


http://stopthedrugwar.org/chronicle/411/sativex.shtml

GW Pharmaceuticals has announced that its marijuana-based drug Sativex will be available on a limited basis to patients in England and Spain. The tincture, applied through a sublingual spray, is currently available by prescription only in Canada. The primary market will be Multiple Sclerosis and cancer patients, although it will be used for other diseases and conditions as well.

Last week, GW announced it had reached an agreement with the Regional Government of Catalonia in Spain to supply Sativex to 600 patients, with initial shipments going out within weeks. 130 of the patients will be MS sufferers, 130 more are neuropathic pain patients, 300 are cancer patients suffering nausea and vomiting from chemotherapy, and 40 more are patients suffering from AIDS wasting syndrome.

The move came at the initiative of the Catalan Health Department, which was responded to patient and doctor requests, and was approved by the Spanish Ministry of Health. The department has already budgeted funds to pay for the drug. The compassionate access program will be evaluated for safety and tolerability

Dr. Rafael Manzanera, General director of Health Resources of the Catalan Health Department, said, "This is a direct response to the wishes of patients with a significant unmet medical need. The Catalan administration believes that a non-smoked prescription cannabis derived medicine, such as Sativex, represents the optimum solution for these patients, without in any way promoting the use of herbal cannabis," said Dr. Rafael Manzanera, general director of health resources for the department.

This week, GW announced that England would become the second European country to make Sativex available to some patients. According to GW, the British Home Office has decided that the drug may be imported from Canada as an unlicensed medicine for prescription to individual MS patients by their doctors. Sativex is yet to be licensed in Britain, but under the Medicines Act, such products may be prescribed if doctors decide it is in the best interest of a particular patient. The government acted in response to inquiries from doctors and patients, GW said.

"This is a move in the right direction," Mike O'Donovan, head of the British MS Society told the BBC. "We believe there is now good evidence that cannabis-derived medicine can relieve distressing symptoms like spasticity and pain in MS. Many people do not find available treatments effective and will now have the opportunity to try a new drug which could significantly improve their quality of life. "We very much hope it will not be long before it is licensed for NHS prescription."

So does GW. The company says it continues "to seek full regulatory approval... for Sativex in the UK." It is conducting Phase III clinical trials and plans to submit an application for marketing authorization next year.

-- END --
Link to Drug War Facts
Please make a generous donation to support Drug War Chronicle in 2007!          

PERMISSION to reprint or redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby granted. We ask that any use of these materials include proper credit and, where appropriate, a link to one or more of our web sites. If your publication customarily pays for publication, DRCNet requests checks payable to the organization. If your publication does not pay for materials, you are free to use the materials gratis. In all cases, we request notification for our records, including physical copies where material has appeared in print. Contact: StoptheDrugWar.org: the Drug Reform Coordination Network, P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202) 293-8344 (fax), e-mail [email protected]. Thank you.

Articles of a purely educational nature in Drug War Chronicle appear courtesy of the DRCNet Foundation, unless otherwise noted.

Issue #411 -- 11/18/05

Drug War Chronicle, recent top items

more...

recent blog posts "In the Trenches" activist feed

SUBSCRIBE TODAY!!!

Editorial: Tell Me Why | Feature: Enhanced Mandatory Minimums Blocked in New Methamphetamine Bill | Feature: The 2005 International Drug Policy Reform Conference in Long Beach, California | Feature: Deported for a Trace -- Farid's Tale | Law Enforcement: This Week's Corrupt Cops Stories | Sports: Under Congressional Pressure, Major League Baseball, Union Agree on Drug Testing Policy | Medical Marijuana: Two Michigan Towns Pass Ordinances -- Officials Balk | Search and Seizure: Supreme Court Hears Search Case Where Wife Consented but Husband Refused | Latin America: Guatemala's Top Narc Arrested in US | Europe: Sativex Coming to England, Spain | Asia: Korean Actress Who Challenged Marijuana Law Sentenced to Prison | Web Scan: In These Times, Alternet on Sembler and Straight, New SSDP Blog | Weekly: This Week in History | Announcement: Senlis Council Seeking Research Proposals on Afghani Opium Licensing Schemes | Job Opportunities: Webmasters for MPP in DC, CRCM in Nevada | Internship Opportunity: Criminal Justice Policy Foundation | Weekly: The Reformer's Calendar |

Mail this article to a friend
Send us feedback on this article
This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
Chronicle archives
Subscribe now!
Out from the Shadows HEA Drug Provision Drug War Chronicle Perry Fund DRCNet en EspaŮol Speakeasy Blogs About Us Home
Why Legalization? NJ Racial Profiling Archive Subscribe Donate DRCNet em PortuguÍs Latest News Drug Library Search
special friends links: SSDP - Flex Your Rights - IAL - Drug War Facts

StoptheDrugWar.org: the Drug Reform Coordination Network (DRCNet)
1623 Connecticut Ave., NW, 3rd Floor, Washington DC 20009 Phone (202) 293-8340 Fax (202) 293-8344 [email protected]